Production (Stage)
Twist Bioscience Corporation
TWST
$28.26
$0.100.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.60% | 4.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.60% | 4.73% | |||
| Cost of Revenue | 1.94% | -1.30% | |||
| Gross Profit | 7.44% | 12.05% | |||
| SG&A Expenses | 13.34% | 5.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.91% | 2.16% | |||
| Operating Income | -19.96% | 3.88% | |||
| Income Before Tax | -24.31% | 9.36% | |||
| Income Tax Expenses | 80.41% | 201.04% | |||
| Earnings from Continuing Operations | -24.48% | 8.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.48% | 8.83% | |||
| EBIT | -19.96% | 3.88% | |||
| EBITDA | -24.38% | 11.64% | |||
| EPS Basic | -23.46% | 9.77% | |||
| Normalized Basic EPS | -23.29% | 10.30% | |||
| EPS Diluted | -23.46% | 9.77% | |||
| Normalized Diluted EPS | -23.29% | 10.30% | |||
| Average Basic Shares Outstanding | 0.82% | 1.04% | |||
| Average Diluted Shares Outstanding | 0.82% | 1.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||